GAZOULI, MARIA
GAZOULI, MARIA
Detection of pathogenic mycobacteria based on functionalized quantum dots coupled with immunomagnetic separation
2011-01-01 Sechi, Leonardo Antonio; Gazouli, Maria; Andreadou, Margarita; Ikonomopoulos, John; Liandris, Emmanouil; Rosu, Valentina
Differential genetic and functional background in inflammatory bowel disease phenotypes of a Greek population: A systems bioinformatics approach
2019-01-01 Gazouli, M.; Dovrolis, N.; Franke, A.; Spyrou, G. M.; Sechi, L. A.; Kolios, G.
Linking chronic infection and autoimmune diseases:Mycobacterium aviumSubspeciesparatuberculosis,SLC11A1polymorphisms and Type-1 diabetes mellitus
2009-01-01 Sechi, Leonardo Antonio; Sieswerda, Lee E.; Rosu, Valentina; Masala, Speranza; Gazouli, Maria; Ikonomopoulos, John; Zanetti, Stefania Anna Lucia; Paccagnini, Daniela; Pacifico, Adolfo; Ahmed, Niyaz
Oral Microbiota as Novel Biomarkers for Colorectal Cancer Screening
2023-01-01 Rezasoltani, Sama; Aghdaei, Hamid Asadzadeh; Jasemi, Seyedesomaye; Gazouli, Maria; Dovrolis, Nikolas; Sadeghi, Amir; Schlüter, Hartmut; Zali, Mohammad Reza; Sechi, Leonardo Antonio; Feizabadi, Mohammad Mehdi
The interplay between mucosal microbiota composition and host gene-expression is linked with infliximab response in inflammatory bowel diseases
2020-01-01 Dovrolis, N.; Michalopoulos, G.; Theodoropoulos, G. E.; Arvanitidis, K.; Kolios, G.; Sechi, L. A.; Eliopoulos, A. G.; Gazouli, M.
Type i and ii interferon signatures can predict the response to anti-Tnf agents in inflammatory bowel disease patients: Involvement of the microbiota
2020-01-01 Mavragani, C. P.; Nezos, A.; Dovrolis, N.; Andreou, N. P.; Legaki, E.; Sechi, L. A.; Bamias, G.; Gazouli, M.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Detection of pathogenic mycobacteria based on functionalized quantum dots coupled with immunomagnetic separation | 1-gen-2011 | Sechi, Leonardo Antonio; Gazouli, Maria; Andreadou, Margarita; Ikonomopoulos, John; Liandris, Emmanouil; Rosu, Valentina | |
| Differential genetic and functional background in inflammatory bowel disease phenotypes of a Greek population: A systems bioinformatics approach | 1-gen-2019 | Gazouli, M.; Dovrolis, N.; Franke, A.; Spyrou, G. M.; Sechi, L. A.; Kolios, G. | |
| Linking chronic infection and autoimmune diseases:Mycobacterium aviumSubspeciesparatuberculosis,SLC11A1polymorphisms and Type-1 diabetes mellitus | 1-gen-2009 | Sechi, Leonardo Antonio; Sieswerda, Lee E.; Rosu, Valentina; Masala, Speranza; Gazouli, Maria; Ikonomopoulos, John; Zanetti, Stefania Anna Lucia; Paccagnini, Daniela; Pacifico, Adolfo; Ahmed, Niyaz | |
| Oral Microbiota as Novel Biomarkers for Colorectal Cancer Screening | 1-gen-2023 | Rezasoltani, Sama; Aghdaei, Hamid Asadzadeh; Jasemi, Seyedesomaye; Gazouli, Maria; Dovrolis, Nikolas; Sadeghi, Amir; Schlüter, Hartmut; Zali, Mohammad Reza; Sechi, Leonardo Antonio; Feizabadi, Mohammad Mehdi | |
| The interplay between mucosal microbiota composition and host gene-expression is linked with infliximab response in inflammatory bowel diseases | 1-gen-2020 | Dovrolis, N.; Michalopoulos, G.; Theodoropoulos, G. E.; Arvanitidis, K.; Kolios, G.; Sechi, L. A.; Eliopoulos, A. G.; Gazouli, M. | |
| Type i and ii interferon signatures can predict the response to anti-Tnf agents in inflammatory bowel disease patients: Involvement of the microbiota | 1-gen-2020 | Mavragani, C. P.; Nezos, A.; Dovrolis, N.; Andreou, N. P.; Legaki, E.; Sechi, L. A.; Bamias, G.; Gazouli, M. |